Daejeon, South Korea

Hyun Ahm Shon


Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inventor Profile: Hyun Ahm Shon

Introduction: Hyun Ahm Shon is an innovative inventor based in Daejeon, South Korea. He has made significant contributions to the field of cancer research through his inventions. His work focuses on developing therapeutic compositions that target specific genetic expressions related to cancer.

Latest Patents: Hyun Ahm Shon holds a patent for a composition that contains inhibitors of the expression or activity of SH3 domain containing ring finger 2 (SH3RF2) for preventing or treating cancer. The invention is designed to utilize an inhibitor that can lower the expression of SH3RF2, a protein whose expression is found to be increased in various cancer tissues. By targeting this protein, the composition aims to promote apoptosis in cancer cells, enhancing their sensitivity to treatment and reducing in vivo tumorigenicity.

Career Highlights: Shon is affiliated with the Korea Research Institute of Bioscience and Biotechnology, where he is engaged in cutting-edge research. His expertise in the field of biosciences has resulted in the development of innovative solutions that have the potential to alter cancer treatment paradigms.

Collaborations: Throughout his career, Hyun Ahm Shon has collaborated with remarkable colleagues such as Kyung Chan Park and Young Il Yeom. Their teamwork exemplifies the strength of collaborative research in advancing scientific knowledge and technological advancements in the biosciences.

Conclusion: Hyun Ahm Shon's contributions to the field of cancer treatment through his patent reflect the importance of innovation in addressing critical health challenges. His work at the Korea Research Institute of Bioscience and Biotechnology not only showcases his talent as an inventor but also highlights the impact of collaborative research in delivering groundbreaking solutions for the medical community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…